Data management platform launched to improve neurotherapeutic research

Neuroscience firm Inscopix, Inc. introduced a cloud-based data management system intended to ease collection, organization and sharing of neuroscience research.

“Inscopix has built a revolutionary, integrated technology [that] will enable scientists to create standardized, customizable push-button workflows that can analyze, store and share datasets across all modalities — from imaging to behavior to electrophysiology — and drive deeper understanding of the brain,” Inscopix CEO Kunal Ghosh, PhD, said in a company release. “This artificial-intelligence-enabled platform will help researchers cut data analysis times from months to weeks or even hours; quickly share and synchronize results with colleagues; and supercharge the potential of these imaging technologies to reveal clinically predictive and precise preclinical models for the discovery and development of the next generation of neurotherapeutics.”

Called Inscopix Data Exploration, Analysis and Sharing (IDEAS), the platform intends to help the whole of the neuroscience community process and analyze data gained from behavioral tools, electrophysiology, photon imaging, microscopy and functional MRI (fMRI). Centralizing the information with the new technology will allow users to retrieve necessary data for a wide variety of tasks securely and much faster than traditional methods of data storage in large files located in places only a single user could access.

“Next-generation imaging technologies are incredibly data-rich and frequently require robust data science and analysis solutions to maximize their potential. IDEAS is a significant advance that bridges the arc between our expertise in neuroscience imaging tools to therapeutic drug discovery,” David Gray, PhD, Inscopix chief scientific officer, noted in the release.

“We’re excited to work with other translationally focused collaborators to catalyze the application of novel high throughput in vivo assays with IDEAS,” Gray said.